This website, including the information available on this website (“Website”), is for informational purposes only and is not intended as, and should not be interpreted as, medical advice or other professional advice. No healthcare provider–patient relationship is created between you and GeriMedRisk through use of this Website. Never disregard professional medical advice or delay in seeking it because of something you have read, heard, or viewed on this Website. The Website is protected by copyright law and is owned by GeriMedRisk or its licensors. Your use of the Website is at your own risk and liability. You may print or download pages of the Website for your personal, legal, non-commercial use provided that you do not modify any of the content or remove or alter any disclaimers or notices. Clinical judgement is still required. GeriMedRisk does not endorse the use of any of these therapies for COVID, but offers this information in the hopes of decreasing the risk of harmful drug-drug interactions or adverse drug events. We will do our best to update this information.
GeriMedRisk COVID-19 Drug Table (updated Feb. 17, 2022)
Fluvoxamine for SARS-CoV2 infection and Older Adults: Pharmacology (January 26, 2022)
Paxlovid COVID Drug Summary (updated Jan. 27, 2022)
Hydroxychloroquine COVID Drug Summary (updated May 13, 2020)
Lopinavir/Ritonavir COVID Drug Summary (updated April 6, 2020)
Azithromycin COVID Drug Summary (updated March 31, 2020)
Tocilizumab COVID Drug Summary (updated April 21, 2020)
Colchicine COVID Drug Summary (updated Feb. 3, 2021)
Dexamethasone COVID Drug Summary (updated Feb. 4, 2021)
Tung JM-H, Bodkin RJ, Wang K, Ganesh V, Neat C, Raber C, et al. Geriatric Pharmacology Infographics: Efficient Knowledge Translation of Medication Optimization for Clinicians Caring for Older Adults. Can Geriatr J. 2019;23(3):140 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6715411/
GeriMedRisk does not necessarily endorse the content on these websites, but they may be helpful.